4.8 Article

A long non-coding RNA links calreticulin-mediated immunogenic cell removal to RB1 transcription

期刊

ONCOGENE
卷 34, 期 39, 页码 5046-5054

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2014.424

关键词

-

资金

  1. Ligue contre le Cancer (equipe labelisee)
  2. Agence National de la Recherche (ANR)
  3. Association pour la recherche sur le cancer (ARC)
  4. Canceropole Ile-de-France
  5. AXA Chair for Longevity Research
  6. Institut National du Cancer (INCa)
  7. Fondation Bettencourt-Schueller
  8. Fondation de France
  9. Fondation pour la Recherche Medicale (FRM)
  10. European Commission (ArtForce)
  11. European Research Council (ERC)
  12. LabEx Immuno-Oncology
  13. SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE)
  14. SIRIC Cancer Research and Personalized Medicine (CARPEM)
  15. Paris Alliance of Cancer Research Institutes (PACRI)
  16. German Ministry of education and research through the Alexander von Humboldt Foundation Sofja Kovalevskaja Award

向作者/读者索取更多资源

A subset of promoters bidirectionally expresses long non-coding RNAs (ncRNAs) of unknown function and protein-coding genes (PCGs) in parallel. Here, we define a set of 1107 highly conserved human bidirectional promoters that mediate the linked expression of long ncRNAs and PCGs. Depletion of the long ncRNA expressed from the RB1 promoter, ncRNA-RB1, reveals regulatory effects different from the RB1-controlled transcriptional program. ncRNA-RB1 positively regulates the expression of calreticulin (CALR) that in response to certain therapeutic interventions can translocate from the endoplasmic reticulum to the cell surface, hence activating anticancer immune responses. Knockdown of ncRNA-RB1 in tumor cells reduced expression of CALR, impaired the translocation of the protein to the cell surface upon treatment with anthracylines and consequently inhibited the cellular uptake by macrophages. In conclusion, co-transcription of ncRNA-RB1 and RB1 provides a positive link between the expression of the two tumor suppressors RB1 and the immune-relevant CALR protein. This regulatory interplay exemplifies disease-relevant co-regulation of two distinct gene products, in which loss of expression of one oncosuppressor protein entails the abolition of additional tumor-inhibitory mechanisms.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据